Table 1.
GRE decay parameters for each participant, tissue, and tumor type
| Participant Type | Tissue | R2 (Hz) | σ (Hz) | n | |||
|---|---|---|---|---|---|---|---|
| Healthy | Muscle - Gluteus Maximus | 44 ± 2 | 36 ± 1 | 29 ± 7 | 3 | ||
| Muscle - Iliopsoas | 39 ± 1 | 33 ± 3 | 20 ± 2 | 3 | |||
| Uterus | 25 ± 1 | 17 ± 3 | 21 ± 3 | 3 | |||
| Cervix | 34 ± 6 | 26 ± 5 | 30 ± 8 | 3 | |||
|
Patients Post- EBRT |
Non- Tumor |
Muscle - Gluteus Maximus | 45 ± 5 | 33 ± 5 | 33 ± 8 | 25 | |
| Muscle - Iliopsoas | 36 ± 6 | 27 ± 6 | 26 ± 7 | 25 | |||
| Tumor | Cervical Tumor | 33 ± 5 | 25 ± 5 | 30 ± 6 | 17 | ||
| Vaginal Tumor | 36 ± 6 | 29 ± 7 | 31 ± 10 | 4 | |||
| Endometrial Tumor | 46 ± 7 | 35 ± 10 | 40 ± 0 | 2 | |||
| Urethra-Bladder Tumor | 35 | 28 | 30 | 1 | |||
| Uterine Tumor | 23 | 16 | 22 | 1 | |||
mean ± standard deviation, n: number of cases